Eugenio Lucia

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia

Enrico Tiacci, Edoardo Simonetti, Monia Capponi et al. · New England Journal of Medicine · 2021 · 122 citations

Medicine, Oncology, Pharmacotherapy +13

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia

Fortunato Morabito, Giovanna Cutrona, Massimo Gentile et al. · British Journal of Haematology · 2009 · 55 citations · Full text

Medicine, Hematology, Oncology +16

LYMPHOCYTIC LEUKEMIA: AN ANALYSIS OF FREQUENCY, DISTRIBUTION AND MORTALITY AT THE UNIVERSITY OF CALIFORNIA HOSPITAL, 1913-1947

Michael B. Shimkin, Eugenio Lucia, Karen Oppermann et al. · Annals of Internal Medicine · 1953 · 26 citations

Medicine, Hematology, Cancer Epidemiology +8

THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL

Enrico Tiacci, Luca De Carolis, Edoardo Simonetti et al. · Hematological Oncology · 2019 · 26 citations

Medicine, Oncology, Pharmacology +11

Pomalidomide in multiple myeloma

Giuseppina Uccello, Annamaria Petrungaro, Carla Mazzone et al. · Expert Opinion on Pharmacotherapy · 2016 · 14 citations · Full text

Medicine, Hematology, Pharmacotherapy +12